Virginia E. Kwitkowski

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski et al. · Journal of Clinical Oncology · 2008 · 337 citations · Full text

Pharmacy, Oncology, Pharmacology +15

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

Virginia E. Kwitkowski, Tatiana M. Prowell, Amna Ibrahim et al. · The Oncologist · 2010 · 249 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 209 citations

Medicine, Oncology, Pharmacology +17

PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Charles S. Cleeland et al. · Value in Health · 2010 · 163 citations

Health Professions, Oncology, Clinical Classification Systems +12

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

Edwin M. Posadas, Meghan S. Liel, Virginia E. Kwitkowski et al. · Cancer · 2007 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17